Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1953 2
1954 4
1957 1
1958 1
1961 2
1962 6
1963 2
1964 4
1965 4
1966 1
1967 1
1968 4
1969 2
1970 2
1971 4
1972 4
1973 7
1974 8
1975 7
1976 6
1977 11
1978 11
1979 19
1980 22
1981 18
1982 15
1983 20
1984 24
1985 39
1986 43
1987 32
1988 64
1989 66
1990 59
1991 45
1992 69
1993 83
1994 110
1995 117
1996 121
1997 148
1998 148
1999 166
2000 191
2001 229
2002 273
2003 294
2004 318
2005 381
2006 434
2007 461
2008 538
2009 608
2010 677
2011 735
2012 923
2013 1064
2014 1124
2015 1243
2016 1331
2017 1382
2018 1611
2019 1900
2020 2219
2021 2592
2022 1405
Text availability
Article attribute
Article type
Publication date

Search Results

21,029 results
Results by year
Filters applied: . Clear all
Page 1
CRISPR-Cas-mediated diagnostics.
Li L, Shen G, Wu M, Jiang J, Xia Q, Lin P. Li L, et al. Among authors: wu m. Trends Biotechnol. 2022 May 17:S0167-7799(22)00104-4. doi: 10.1016/j.tibtech.2022.04.006. Online ahead of print. Trends Biotechnol. 2022. PMID: 35595574 Review.
Fundamental immune-oncogenicity trade-offs define driver mutation fitness.
Hoyos D, Zappasodi R, Schulze I, Sethna Z, de Andrade KC, Bajorin DF, Bandlamudi C, Callahan MK, Funt SA, Hadrup SR, Holm JS, Rosenberg JE, Shah SP, Vázquez-García I, Weigelt B, Wu M, Zamarin D, Campitelli LF, Osborne EJ, Klinger M, Robins HS, Khincha PP, Savage SA, Balachandran VP, Wolchok JD, Hellmann MD, Merghoub T, Levine AJ, Łuksza M, Greenbaum BD. Hoyos D, et al. Among authors: wu m. Nature. 2022 Jun;606(7912):172-179. doi: 10.1038/s41586-022-04696-z. Epub 2022 May 11. Nature. 2022. PMID: 35545680 Free PMC article.
EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.
Wu Q, Zhen Y, Shi L, Vu P, Greninger P, Adil R, Merritt J, Egan R, Wu MJ, Yin X, Ferrone CR, Deshpande V, Baiev I, Pinto CJ, McLoughlin DE, Walmsley CS, Stone JR, Gordan JD, Zhu AX, Juric D, Goyal L, Benes CH, Bardeesy N. Wu Q, et al. Among authors: wu mj. Cancer Discov. 2022 May 2;12(5):1378-1395. doi: 10.1158/2159-8290.CD-21-1168. Cancer Discov. 2022. PMID: 35420673
Results of Two Cases of Pig-to-Human Kidney Xenotransplantation.
Montgomery RA, Stern JM, Lonze BE, Tatapudi VS, Mangiola M, Wu M, Weldon E, Lawson N, Deterville C, Dieter RA, Sullivan B, Boulton G, Parent B, Piper G, Sommer P, Cawthon S, Duggan E, Ayares D, Dandro A, Fazio-Kroll A, Kokkinaki M, Burdorf L, Lorber M, Boeke JD, Pass H, Keating B, Griesemer A, Ali NM, Mehta SA, Stewart ZA. Montgomery RA, et al. Among authors: wu m. N Engl J Med. 2022 May 19;386(20):1889-1898. doi: 10.1056/NEJMoa2120238. N Engl J Med. 2022. PMID: 35584156
Peroxiredoxin, Senescence, and Cancer.
Wu M, Deng C, Lo TH, Chan KY, Li X, Wong CM. Wu M, et al. Cells. 2022 May 28;11(11):1772. doi: 10.3390/cells11111772. Cells. 2022. PMID: 35681467 Free PMC article. Review.
The Progress of Decellularized Scaffold in Stomatology.
Zeng A, Li H, Liu J, Wu M. Zeng A, et al. Among authors: wu m. Tissue Eng Regen Med. 2022 Jun;19(3):451-461. doi: 10.1007/s13770-022-00432-w. Epub 2022 Mar 23. Tissue Eng Regen Med. 2022. PMID: 35320505 Free PMC article. Review.
COVID-19 in Veterans: A Narrative Review.
Chuang YC, Tsai HW, Liu SA, Wu MJ, Liu PY. Chuang YC, et al. Among authors: wu mj. Risk Manag Healthc Policy. 2022 Apr 26;15:805-815. doi: 10.2147/RMHP.S354814. eCollection 2022. Risk Manag Healthc Policy. 2022. PMID: 35502442 Free PMC article. Review.
21,029 results
You have reached the last available page of results. Please see the User Guide for more information.